Teasing apart structural determinants of `toxicity' and `adjuvanticity': implications for meningococcal vaccine development

Abstract

The use of lipopolysaccharide (LPS) as an adjuvant is limited by its high endotoxic activity. In particular, the fatty-acyl pattern of the lipid A part of LPS has been demonstrated to determine its biological activity. By genetic modification of the lipid A biosynthesis pathway in Neisseria meningitidis, a panel of recombinant strains with specific alterations in the lipid A acylation pattern, as well as a strain completely lacking LPS were isolated. Whereas all variations in the fatty-acyl pattern resulted in reduced endotoxic activity, as measured by TNF-α induction in the human macrophage cell line MM6, the adjuvant activity of the modified LPS was, in most cases, barely affected. The in vivo adjuvant properties of N. meningitidis wild-type and mutant LPS was found to correlate with induction of co-stimulatory molecules, in particular CD80 and CD40, and with IL-12 production by LPS-stimulated bone marrow-derived BALB/c dendritic cells in vitro. Our results suggest that the ability of LPS to stimulate pro-inflammatory cytokine induction is not necessarily linked to its adjuvant activity. The availability of this novel set of lipid A variants with improved pharmacological properties will be of great importance for the improvement of future outer membrane vesicle vaccines against N. meningitidis.

Keywords

Neisseria meningitidis lipid A mutants endotoxicity adjuvanticity outer membrane vesicle vaccines

References

Raetz Crh. Structure and biosynthesis of lipid A of Escherichia coli. In: Neidhardt FC , Ingraham JL , Magasanik B , Low KB , Schaechter M , Umbarger HE. (eds) Escherichia coli and Salmonellatyphimurium Cellular and Molecular Biology. Washington, DC: American Society for Microbiology, 1987; 498—503.

Takada H. , Kotani S. Structural requirements of lipid A for endotoxicity and other biological activities . Crit Rev Microbiol 1989; 16: 477—523.

Kulshin VA , Zähringer U. , Lindner B. et al. Structural characterization of the lipid A component of pathogenic Neisseria meningitidis. J Bacteriol 1992; 174: 1793—1800.

van der Ley P. , Heckels JE , Virji M. , Hoogerhout P. , Poolman JT Topology of outer membrane porins in pathogenic Neisseria spp. Infect Immun 1991; 59: 2963—2971.

Karkhanis YD , Zeltner JY , Jackson JJ , Carlo DJ A new and improved microassay to determine 2-keto-3-deoxyoctonatein lipopolysaccharide of Gram-negative bacteria. Anal Biochem 1978 ; 85: 595—601.

Ziegler-Heitbrock HW , Thiel E. , Futterer A. , Herzog V. , Wirtz A. , Riethmuller G. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer 1988; 41: 456—461.

Espevik T. , Nissen MJ A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986; 95: 99—105.

Abdillahi H. , Poolman J. Whole cell ELISA for typing Neisseria meningitidis with monoclonal antibodies . FEMS Microbiol Lett 1987; 48: 367—-371.

Hoogerhout P. , Donders EM , van Gaans-van den Brink JA et al. Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidis. Infect Immun 1995; 63: 3473—3478.

10.

Inaba K. , Inaba M. , Romani N. et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693—1702.

11.

Steeghs L. , Berns M. , ten Hove J. et al. Expression of foreign LpxA acyltransferases in Neisseria meningitidis results in modified lipid A with reduced toxicity and retained adjuvant activity . Cell Microbiol 2002; 4: 599—611.

12.

van der Ley P. , Steeghs L. , Hamstra HJ , ten Hove J. , Zomer B. , van Alphen L. Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity and adjuvant activity. Infect Immun 2001; 69: 5981—5990.

13.

Steeghs L. , den Hartog R. , den Boer A. et al. Meningitis bacterium is viable without endotoxin. Nature 1998; 392: 449—450.

14.

Steeghs L. , de Cock H. , Evers E. , Zomer B. , Tommassen J. , van der Ley P. Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant. EMBO J 2001; 20: 6937—6945.

15.

Poltorak A. , He X. , Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in tlr4 gene. Science 1998; 282: 2085—2088.

16.

Takeuchi O. , Hoshino K. , Kawai T. et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components . Immunity 1999; 11: 443—451.

17.

Nagai Y. , Akashi S. , Masakazu N. et al. Essential role for MD-2 in LPS responsiveness and TLR4 distribution . Nat Immunol 2002; 3: 667—672.

18.

Golenbock DT , Hampton RY , Qureshi N. , Takayama K. , Raetz CR Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 1991; 266: 19490—19498.

19.

Kirkland TN , Qureshi N. , Takayama K. Diphosphoryl lipid A derived from lipopolysaccharide (LPS) of Rhodopseudomonas sphaeroides inhibits activation of 70Z/3 cells by LPS. Infect Immun 1991; 59: 131—136.

20.

Lien E. , Means TK , Heine H. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide . J Clin Invest 2000; 105: 497—504.

21.

Poltorak A. , Ricciardi-Castagnoli P. , Citterio S. , Beutler B. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation . Proc Natl Acad Sci USA 2000; 97: 2163—2167.

22.

Tanamoto K. , Azumi S. Salmonella-type heptaacylated lipid A is inactive and acts as an antagonist of lipopolysaccharide action on human line cells . J Immunol 2000; 164: 3149—3156.

23.

Ingalls RR , Lien E. , Golenbock DT Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through Toll-like receptor 2. Infect Immun 2001; 69: 2230—2236.

24.

Pridmore AC , Wyllie DH , Abdillahi F. et al. A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via Toll-like receptor (TLR) 2 but not via TLR4/MD2. J Infect Dis 2001; 183: 89—96.

25.

Uronen-Hansson H. , Steeghs L. , Allen J. et al. Human dendritic cell activation by Neisseria meningitidis: phagocytosis depends on expression of lipooligosaccharide (LOS) by the bacteria and is required for optimal cytokine production. Cell Microbiol 2004; In press.